Evidence map›Paper›PMID 41551632›Full record

ArticleIEEE journal of selected topics in signal processing2025

Speech Acoustic Markers Can Detect Mild Cognitive Impairment in Parkinson's Disease.

Kara M Smith, James R Williamson, Thomas F Quatieri

Abstract read
In one paragraph

Article in IEEE journal of selected topics in signal processing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kara M SmithDepartment of Neurology, Boston Medical Center, Boston, MA 02118 USA.ORCID 0000-0003-2760-9812
James R WilliamsonMassachusetts Institute of Technology Lincoln Laboratories, Lexington, MA 02421 USA.ORCID 0000-0001-9449-3616
Thomas F QuatieriMassachusetts Institute of Technology Lincoln Laboratories, Lexington, MA 02421 USA, and also with the Speech and Hearing Bioscience and Technology Program, Harvard Medical School, Cambridge, MA 02115 USA.ORCID 0000-0003-1925-6340

Funding

Speech markers of cognitive impairment in Parkinson's diseaseK23DC016656 · NIDCD · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SMITH, KARA MICHELLE · 2019 to 2023
$946k
NIDCD NIH HHS K23 DC016656
6 · The paper itself

Abstract

Background: Speech biomarkers have been used to assess motor dysfunction in people with Parkinson's disease (PD), but speech biomarkers for mild cognitive impairment in PD (PD-MCI) have not been well studied. Objective: To identify speech acoustic features associated with PD-MCI and evaluate the performance of a model to discriminate PD-MCI from participants with normal cognitive status (PD-NC). Methods: We analyzed speech samples from 42 participants with PD, diagnosed as either PD-MCI or PD-NC using the Movement disorders Society Task Force Tier II criteria as a gold-standard classification of MCI. A reading passage and a picture description task were analyzed for acoustic features, which were used to generate individual and then a final fused Gaussian mixture model (GMM) to discriminate PD-MCI and PD-NC participants. Results: The picture description task yielded a larger number of acoustic features that were highly associated with PD-MCI status compared to the reading task. Fusing the model outputs from the picture description task resulted in an AUC = 0.82 for discriminating PD-MCI from PD-NC participants. The acoustic features associated with PD-MCI stemmed from multiple speech subsystems. Conclusion: PD-MCI has a distinct speech acoustic signature that may be harnessed to develop better tools to detect and monitor this complication.

Indexed as

Acousticscognitive dysfunctionParkinson diseasespeech

Identifiers

PMID41551632
PMCPMC12807506

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.